ストックスクリーナーアプリを入手
1.365
1.09%
-0.015
アフターアワーズ：
1.38
0.015
+1.10%
Psyence Biomedical Ltd (PBM) 最新ニュース
Psyence Biomedical Ltd (PBM) Stock: A Value Analysis - The News Heater
Ratio Analysis: Unpacking Psyence Biomedical Ltd (PBM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Psyence Biomedical Adjusts Financials for Reverse Stock Split - TipRanks
Short Interest in Psyence Biomedical Ltd. (NASDAQ:PBMWW) Decreases By 41.0% - Defense World
Psyence enters into $25M common stock purchase agreement with White Lion Capital - MSN
Psyence Biomedical Issues Pre-Funded Share Purchase Warrant - TipRanks
Psyence Biomed Announces Closing of $2.0 Million Private Placement - The Manila Times
Psyence Biomed (PBM) Raises $2M in Private Placement with Warrant Coverage, Led by H.C. Wainwright - StockTitan
Psyence Biomedical Regains Nasdaq Compliance, Fortifying Market Position - Yahoo Finance
Psyence Biomed announces $2 million private placement By Investing.com - Investing.com Nigeria
PBMPsyence Biomedical Ltd. Common Shares Latest Stock News & Market Updates - StockTitan
Psyence Unveils Private Placement - Baystreet.ca
Psyence Biomed announces $2 million private placement - Investing.com
Psyence Biomed Announces $2.0 Million Private Placement - The Manila Times
Psyence Biomed Secures $2M Private Placement with Strategic Warrant Offering - StockTitan
Psyence Biomedical Achieves Full Nasdaq Compliance, Advances Clinical Trial Plans with $5.6M War Chest - StockTitan
Financial Genius or Just Lucky? Psyence Biomedical Defies Nasdaq Odds! - Jomfruland.net
US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' - Benzinga
US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' - Benzinga
Psyence Biomedical Signs Exclusive Licensing Agreement with Optimi Health - TipRanks
Psyence Biomedical Advances in Phase IIb Psilocybin Clinical Trial - TipRanks
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial - The Manila Times
Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial - Newsfile
Psyence Biomedical executes binding agreements with Optimi Health - Yahoo Finance
Psyence Biomedical stock soars on binding agreements with Optimi Health - MSN
Psyence Biomed Executes Binding Agreements with Optimi Health Corp - Marketscreener.com
Psyence Biomed Executes Binding Agreements with Optimi Health Corp. - The Manila Times
Psyence Biomed Secures Landmark Global Psilocybin Supply Deal for Palliative Care Drug Development - StockTitan
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations - The Manila Times
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle - EIN News
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Psyence Biomedical Boosts Equity to Meet Nasdaq Rules - TipRanks
Psyence Biomedical Revises Debt-for-Equity Deal - TipRanks
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress By Investing.com - Investing.com Canada
Psyence Biomed Strengthens Position with Valuable Stake and Trials - TipRanks
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress - The Manila Times
Psyence Biomedical issues letter to shareholders - TipRanks
Psyence Biomedical Ltd trading halted, news pending - TipRanks
Psyence Biomed granted Nasdaq listing extension By Investing.com - Investing.com Australia
Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards - Benzinga
Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing - Green Market Report
Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing - The Manila Times
Psyence Biomed granted Nasdaq listing extension - Investing.com
Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing - XM
Psyence Biomedical Secures Nasdaq Extension, Plans 1-for-75 Share Consolidation | PBM Stock News - StockTitan
Psyence Biomedical fell on 75-to-1 share consolidation and Nasdaq delisting notice - MSN
1.03%
大文字化:
|
ボリューム (24 時間):